Literature DB >> 22076607

shRNA against CD44 inhibits cell proliferation, invasion and migration, and promotes apoptosis of colon carcinoma cells.

Yeon Sun Park1, Jung Wook Huh, Jae Hyuk Lee, Hyeong Rok Kim.   

Abstract

CD44 is a causal factor for tumor invasion, metastasis and acquisition of resistance to apoptosis. CD44 knockdown using inducible short hairpin RNA (shRNA) significantly reduces cell growth and invasion. Short hairpin RNA against CD44 and pGFP-V-RS-vector was used for knockdown of CD44 expression in SW620 colon cancer cells. Cell growth, invasion and migration assay, immunofluorescence for β-catenin expression and western blotting for Wnt signaling molecules were analyzed. Cell cycle analysis and western blot analysis for apoptotic molecules were evaluated. Short hairpin RNA against CD44 reduced the expression of CD44. Cell proliferation, migration and invasion were markedly inhibited and apoptosis was increased in shRNA CD44-transfected cells. Knockdown of CD44 decreased the phosphorylation of PDK1, Akt and GSK3β, and β-catenin levels. Decreased phosphorylated Akt led to an increase in phosphorylated FoxO1 and induced cell cycle arrest in the G0-G1 phase and a decrease in the S phase. The levels of Bcl-2 and Bcl-xL expression were down-regulated, while the levels of BAX expression and cleaved caspase-3, -8 and -9 were increased. CD44 knockdown by way of shRNA inhibited cell proliferation and induced cell apoptosis. This can be used as a therapeutic intervention with the anti-survival/pro-apoptotic machinery in human colon cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22076607     DOI: 10.3892/or.2011.1532

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  21 in total

1.  Cluster of Differentiation 44 (CD44) Gene Variants: A Putative Cancer Stem Cell Marker in Risk Prediction of Bladder Cancer in North Indian Population.

Authors:  Archana Verma; Rakesh Kapoor; Rama Devi Mittal
Journal:  Indian J Clin Biochem       Date:  2016-05-21

2.  Inhibition of CD44 induces apoptosis, inflammation, and matrix metalloproteinase expression in tendinopathy.

Authors:  Po-Ting Wu; Wei-Ren Su; Chia-Lung Li; Jeng-Long Hsieh; Ching-Hou Ma; Chao-Liang Wu; Li-Chieh Kuo; I-Ming Jou; Shih-Yao Chen
Journal:  J Biol Chem       Date:  2019-11-15       Impact factor: 5.157

3.  MTI-101 (cyclized HYD1) binds a CD44 containing complex and induces necrotic cell death in multiple myeloma.

Authors:  Anthony W Gebhard; Priyesh Jain; Rajesh R Nair; Michael F Emmons; Raul F Argilagos; John M Koomen; Mark L McLaughlin; Lori A Hazlehurst
Journal:  Mol Cancer Ther       Date:  2013-09-18       Impact factor: 6.261

4.  Physcion inhibits the metastatic potential of human colorectal cancer SW620 cells in vitro by suppressing the transcription factor SOX2.

Authors:  Yan-tao Han; Xue-hong Chen; Hui Gao; Jun-li Ye; Chun-bo Wang
Journal:  Acta Pharmacol Sin       Date:  2015-12-28       Impact factor: 6.150

5.  Curcumin promotes autophagic survival of a subset of colon cancer stem cells, which are ablated by DCLK1-siRNA.

Authors:  Carla Kantara; Malaney O'Connell; Shubhashish Sarkar; Stephanie Moya; Robert Ullrich; Pomila Singh
Journal:  Cancer Res       Date:  2014-03-13       Impact factor: 12.701

6.  Knockdown of CD44 enhances chemosensitivity of acute myeloid leukemia cells to ADM and Ara-C.

Authors:  Ni-sha Wang; Min Wei; Wen-li Ma; Wei Meng; Wen-ling Zheng
Journal:  Tumour Biol       Date:  2013-12-28

7.  Maslinic acid-enriched diet decreases intestinal tumorigenesis in Apc(Min/+) mice through transcriptomic and metabolomic reprogramming.

Authors:  Susana Sánchez-Tena; Fernando J Reyes-Zurita; Santiago Díaz-Moralli; Maria Pilar Vinardell; Michelle Reed; Francisco García-García; Joaquín Dopazo; José A Lupiáñez; Ulrich Günther; Marta Cascante
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

8.  Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications.

Authors:  Malaney R O'Connell; Shubhashish Sarkar; Gurinder K Luthra; Yoshinaga Okugawa; Yuji Toiyama; Aakash H Gajjar; Suimin Qiu; Ajay Goel; Pomila Singh
Journal:  Sci Rep       Date:  2015-10-08       Impact factor: 4.379

Review 9.  Key Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem Cells.

Authors:  Theerawut Chanmee; Pawared Ontong; Koji Kimata; Naoki Itano
Journal:  Front Oncol       Date:  2015-08-10       Impact factor: 6.244

10.  BMP-2 induces versican and hyaluronan that contribute to post-EMT AV cushion cell migration.

Authors:  Kei Inai; Jessica L Burnside; Stanley Hoffman; Bryan P Toole; Yukiko Sugi
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.